Ykt6 is implicated in a Sec17-independent early reaction. (A) Palmitoylation of Vac8 is specifically inhibited by antibodies to Ykt6 and Sec18. Fusion reactions (300 μl) containing 60 μg of vacuoles from BJ3505 were incubated for 10 min at 26°C in the presence of ATP (0.5 mM), cytosol (0.5 μg/μl), coenzyme A (CoA, 10 μM), [3H]-palmitate (150 μCi), and either purified IgGs to the indicated proteins or recombinant Ykt6-R71G (15 μM) or an equal volume of PS buffer (20 mM PIPES/KOH, 200 mM sorbitol). Vacuoles were then isolated by centrifugation (10 min, 12 000 g, 4°C), washed with 500 μl of PSK buffer (20 mM PIPES/KOH, pH 6.8, 200 mM sorbitol, 150 mM KCl) and resuspended in SDS sample buffer without 2-mercaptoethanol. Palmitoylated Vac8 was identified by SDS–PAGE and fluorography. Bands were quantified by laser densitometry (IPLab GelH, Scientific Image Processing 1.5, Signal Analytics). The positive control was set to 100%. (B) Interference with Ykt6 blocks fusion. Standard fusion reactions were incubated for 60 min at 26°C in the presence of Ykt6-R71G (15 μM) or anti-Ykt6 antibodies. The inhibiting amounts of protein were determined by titration (see Figure 1C). Background activity was subtracted from all measurements. Fusion activity in the absence of inhibitor was set to 100%. (C) Inhibition of fusion by Ykt6-R71G, but not Ykt6-wt. Indicated amounts of purified Ykt6 proteins were added to standard fusion reactions. Alkaline phosphatase activity was determined after 90 min at 26°C. (D) Sec17 release is unaffected by Ykt6-R71G. BJ3505 vacuoles were incubated for 10 min at 26°C in a 150 μl reaction containing 200 ng/ml Sec18 in the presence or absence of Ykt6-R71G (15 μM), anti-Ykt6 (inactive), anti-Ykt6, anti-Vam3, anti-Nyv1, anti-Sec17 or anti-Sec18. Then vacuoles were placed on ice, centrifuged (5 min, 16 000 g, 4°C) and washed twice with 500 μl PSK buffer. Vacuoles were analyzed by immunoblotting with anti-Sec17 and anti-Vam3 antibodies. (E) Excess recombinant Sec17 blocks palmitoylation. Palmitoylation reactions were performed as in (A). Recombinant Sec17 (7 μmol) or Sec18 (12.5 μmol) was added where indicated. At the same concentration, Sec17 inhibited the fusion reaction completely (data not shown), in agreement with previous studies (Wang et al, 2000).